Ke X - Search Results

1

Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease.

Power TP, Ke X, Zhao Z, Bonine NG, Cziraky MJ, Grabner M, Barron JJ, Quimbo R, Vangerow B, Toth PP. Power TP, et al. Among authors: ke x. Vasc Health Risk Manag. 2018 Feb 5;14:23-36. doi: 10.2147/VHRM.S146266. eCollection 2018. Vasc Health Risk Manag. 2018. PMID: 29440909 Free PMC article.

2

A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies.

Wei W, Buysman E, Grabner M, Xie L, Brekke L, Ke X, Chu JW, Levin PA. Wei W, et al. Among authors: ke x. Diabetes Obes Metab. 2017 Mar;19(3):375-386. doi: 10.1111/dom.12828. Epub 2017 Jan 20. Diabetes Obes Metab. 2017. PMID: 27860158 Free PMC article.

3

The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study.

Brekke L, Buysman E, Grabner M, Ke X, Xie L, Baser O, Wei W. Brekke L, et al. Among authors: ke x. Value Health. 2017 Dec;20(10):1252-1259. doi: 10.1016/j.jval.2017.05.019. Epub 2017 Jul 11. Value Health. 2017. PMID: 29241884 Free article.

4

Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.

Ke X, Marvel J, Yu TC, Wertz D, Geremakis C, Wang L, Stephenson JJ, Mannino DM. Ke X, et al. Int J Chron Obstruct Pulmon Dis. 2016 Jul 27;11:1689-703. doi: 10.2147/COPD.S108967. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27555759 Free PMC article.

5

A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings.

Ke X, Eisenberg Lawrence DF, Oglesby A, Patel J, Kan H, Boggs R. Ke X, et al. Clin Ther. 2015 Dec 1;37(12):2852-63. doi: 10.1016/j.clinthera.2015.10.008. Epub 2015 Nov 4. Clin Ther. 2015. PMID: 26547483 Free article.

6

Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.

Ke X, Kavati A, Wertz D, Huang Q, Wang L, Willey VJ, Stephenson JJ, Ortiz B, Paknis B, Bernstein JA, Beck LA. Ke X, et al. J Manag Care Spec Pharm. 2018 Jul;24(7):598-606. doi: 10.18553/jmcp.2018.24.7.598. J Manag Care Spec Pharm. 2018. PMID: 29952712 Free PMC article.

7

Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria.

Wang L, Ke X, Kavati A, Wertz D, Huang Q, Willey VJ, Stephenson JJ, Ortiz B, Paknis B, Bernstein JA, Beck LA. Wang L, et al. Among authors: ke x. Curr Med Res Opin. 2018 Jan;34(1):35-39. doi: 10.1080/03007995.2017.1395732. Epub 2017 Nov 10. Curr Med Res Opin. 2018. PMID: 29064325

8

Determinants of high cost in multiple sclerosis patients: a claims and chart review study.

Ke X, Navaratnam P, Sasane R, Eisenberg Lawrence DF, Friedman HS, Tulsi BB, Vollmer T. Ke X, et al. Curr Med Res Opin. 2016 Sep;32(9):1589-97. doi: 10.1080/03007995.2016.1192529. Epub 2016 Jun 25. Curr Med Res Opin. 2016. PMID: 27207562

9

[No title available]

[No authors listed] [No authors listed] PMID: 29406838

10

Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab.

Ke X, Kavati A, Wertz D, Huang Q, Wang L, Willey VJ, Stephenson JJ, Ortiz B, Panettieri RA Jr,, Corren J. Ke X, et al. Clin Ther. 2018 Jul;40(7):1140-1158.e4. doi: 10.1016/j.clinthera.2018.05.014. Epub 2018 Jul 23. Clin Ther. 2018. PMID: 30049502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,268 results

Search Page

Filters